Costa, Gabriela Maria Dangelo; Pinto, Claudinéia Aparecida Sales de Oliveira 
; Silva, Vânia Rodrigues Leite e; Baby, André Rolim ; Velasco, Maria Valéria Robles
Source: American Association of Pharmaceutical Scientists/AAPS. Unidade: FCF
Subjects: VITAMINA D, PELE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Gabriela Maria Dangelo et al. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation. American Association of Pharmaceutical Scientists/AAPS, v. 19, p. 2418-2425, 2018Tradução . . Disponível em: https://doi.org/10.1208/s12249-018-1065-5. Acesso em: 09 jun. 2024.APA
Costa, G. M. D., Pinto, C. A. S. de O., Silva, V. R. L. e, Baby, A. R., & Velasco, M. V. R. (2018). Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation. American Association of Pharmaceutical Scientists/AAPS, 19, 2418-2425. doi:10.1208/s12249-018-1065-5NLM
Costa GMD, Pinto CAS de O, Silva VRL e, Baby AR, Velasco MVR. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation [Internet]. American Association of Pharmaceutical Scientists/AAPS. 2018 ; 19 2418-2425.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1208/s12249-018-1065-5Vancouver
Costa GMD, Pinto CAS de O, Silva VRL e, Baby AR, Velasco MVR. Is Vitamin 'D IND. 3' transdermal formulation feasible? an ex vivo skin retention and permeation [Internet]. American Association of Pharmaceutical Scientists/AAPS. 2018 ; 19 2418-2425.[citado 2024 jun. 09 ] Available from: https://doi.org/10.1208/s12249-018-1065-5
